{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:12:50Z","timestamp":1780405970950,"version":"3.54.1"},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Cases"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>Glaucoma is caused by increased intraocular pressure (IOP) that damages the optic nerve, leading to blindness. The Ahmed glaucoma valve (AGV) is a glaucoma drainage implant device that is used in glaucoma patients with uncontrolled IOP. A possible complication after any ocular surgery however is hyphema, which can itself progress to uveitis glaucoma hyphema (UGH) syndrome on rare occasions. UGH syndrome has not yet been reported as a complication of AGV implantation.<\/jats:p>\n          <jats:p>CASE SUMMARY<\/jats:p>\n          <jats:p>Here, we have reported a case of a 55-year-old female who developed both hyphema and pigmentation as a result of AGV implantation. We confirmed UGH syndrome secondary to AGV implantation after the patient underwent another surgery to shorten and reposition the AGV tube. After the second surgery, the patient\u2019s IOP was reduced, and she had a clear cornea and no signs of hyphema.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>This first report of UGH syndrome as a complication of AGV implantation reminds clinicians that frequent follow-up is paramount.<\/jats:p>","DOI":"10.12998\/wjcc.v12.i28.6217","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T02:24:40Z","timestamp":1723515880000},"page":"6217-6221","source":"Crossref","is-referenced-by-count":2,"title":["Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report"],"prefix":"10.12998","volume":"12","author":[{"given":"Rahaf Jalal","family":"Altwijri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Alsirhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S104220"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0503-1"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)73755-9"},{"key":"B5","doi-asserted-by":"crossref","unstructured":"Zhou MW, Wang W, Huang WB, Chen SD, Li XY, Gao XB, Zhang XL. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl) 2013; 126: 1412-1417","DOI":"10.3760\/cma.j.issn.0366-6999.20130011"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14477"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(84)90113-9"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2022.2156547"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2017.3"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2020.06.12"},{"key":"B11","unstructured":"Sen S, Zeppieri M, Tripathy K.   Uveitis Glaucoma Hyphema Syndrome. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2009.01920.x"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10008-1180"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0886-3350(88)80153-6"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2017.02.026"},{"key":"B16","unstructured":"Zeppieri M. Pigment dispersion syndrome: A brief overview. J Clin Transl Res 2022; 8: 344-350"},{"key":"B17","unstructured":"Kocov\u00e1 H, Vlkov\u00e1 E, Michalcov\u00e1 L, Ryb\u00e1rov\u00e1 N, Motyka O. Incidence of cataract following implantation of a posterior-chamber phakic lens ICL (Implantable Collamer Lens) - long-term results. Cesk Slov Oftalmol 2017; 73: 87-93"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032869"},{"key":"B19","unstructured":"Chopra V, Arora S, Francis BA. Not a Routine Case ofPigmentary DispersionSyndrome or UveiticGlaucoma. Challeng Cases 2015; 18-21"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i28\/6217.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i28\/6217.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T02:25:39Z","timestamp":1723515939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i28\/6217.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,6]]},"references-count":19,"journal-issue":{"issue":"28"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v12.i28.6217","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,6]]}}}